These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11196200

  • 1. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma.
    Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K.
    Cancer Res; 2001 Jan 01; 61(1):71-5. PubMed ID: 11196200
    [Abstract] [Full Text] [Related]

  • 2. Genetic disruption of host interferon-gamma drastically enhances the metastasis of pancreatic adenocarcinoma through impaired expression of inducible nitric oxide synthase.
    Wang B, Xiong Q, Shi Q, Le X, Xie K.
    Oncogene; 2001 Oct 18; 20(47):6930-7. PubMed ID: 11687972
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
    Xie K, Bielenberg D, Huang S, Xu L, Salas T, Juang SH, Dong Z, Fidler IJ.
    Clin Cancer Res; 1997 Dec 18; 3(12 Pt 1):2283-94. PubMed ID: 9815626
    [Abstract] [Full Text] [Related]

  • 6. Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase.
    Wei D, Richardson EL, Zhu K, Wang L, Le X, He Y, Huang S, Xie K.
    Cancer Res; 2003 Jul 15; 63(14):3855-9. PubMed ID: 12873972
    [Abstract] [Full Text] [Related]

  • 7. Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.
    Shi Q, Huang S, Jiang W, Kutach LS, Ananthaswamy HN, Xie K.
    Cancer Res; 1999 May 01; 59(9):2072-5. PubMed ID: 10232590
    [Abstract] [Full Text] [Related]

  • 8. IFN-alpha beta reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase.
    Jiang H, Rummage JA, Zhou A, Chen Z, Herriot MJ, Stewart CA, Kolosov M, Leu RW.
    J Immunol; 1996 Jul 01; 157(1):305-12. PubMed ID: 8683131
    [Abstract] [Full Text] [Related]

  • 9. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
    Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ.
    J Immunol; 1998 Nov 01; 161(9):4803-10. PubMed ID: 9794412
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
    Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG.
    Cancer Res; 2001 Apr 01; 61(7):3182-7. PubMed ID: 11306506
    [Abstract] [Full Text] [Related]

  • 11. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
    Zhang F, Lu W, Dong Z.
    Clin Cancer Res; 2002 Sep 01; 8(9):2942-51. PubMed ID: 12231540
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages.
    Jun CD, Choi BM, Kim SU, Lee SY, Kim HM, Chung HT.
    Immunology; 1995 May 01; 85(1):114-9. PubMed ID: 7635512
    [Abstract] [Full Text] [Related]

  • 13. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
    Calderon CL, Torroella-Kouri M, Dinapoli MR, Lopez DM.
    Int J Oncol; 2008 Mar 01; 32(3):713-21. PubMed ID: 18292949
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R, Zheng SX, Tang W, He PL, Li XY, Yang YF, Li YC, Geng JG, Zuo JP.
    J Pharmacol Exp Ther; 2006 Jan 01; 316(1):121-8. PubMed ID: 16166270
    [Abstract] [Full Text] [Related]

  • 15. Effects of endothelial nitric oxide synthase gene expression on the tumor biology of human oral carcinoma SCC-25 cells.
    Liu R, Oberley TD, Oberley LW.
    Cell Growth Differ; 1998 Mar 01; 9(3):239-46. PubMed ID: 9543390
    [Abstract] [Full Text] [Related]

  • 16. KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
    Inoue T, Hamada Y, Takeshita K, Fukushima K, Higaki M.
    J Rheumatol; 2001 Jun 01; 28(6):1229-37. PubMed ID: 11409114
    [Abstract] [Full Text] [Related]

  • 17. Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
    Gauthier N, Lohm S, Touzery C, Chantôme A, Perette B, Reveneau S, Brunotte F, Juillerat-Jeanneret L, Jeannin JF.
    Carcinogenesis; 2004 Sep 01; 25(9):1559-65. PubMed ID: 15059928
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 in combination with interferon-gamma and tumor necrosis factor-alpha enhances in vitro production of nitric oxide by murine resident paritoneal macrophage.
    Zidek Z, Franková D.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):25-32. PubMed ID: 10210769
    [Abstract] [Full Text] [Related]

  • 19. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.
    Takahashi M, Mutoh M, Shoji Y, Kamanaka Y, Naka M, Maruyama T, Sugimura T, Wakabayashi K.
    Oncogene; 2003 Oct 23; 22(48):7667-76. PubMed ID: 14576830
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M, Proietti E, Santodonato L, Gabriele L, Peretti M, Plavec I, Meyer F, Kaido T, Gresser I, Belardelli F.
    Cancer Res; 1993 Mar 01; 53(5):1107-12. PubMed ID: 8439955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.